Dr. Mona Oliveira is CEO and founder of Biolinker synthetic biology startup, which masters genetic engineering technologies for recombinant protein production in an accelerated way and with less risk of failure. Top 7 Biotech startup in Brazil in 2022. Top 500 best biotech startup worldwide in 2019 Hello Tomorrow and top40 at Wolves summit 2018. Finalist by Finep in 2021 in the innovative women program and winner of the USP highlight award for former students in innovation and entrepreneurship in 2022. Mother of two children, career scientist with publications in international annals and more than 17 products launched in Brazil. Her company started exporting services in 2022 and seeks to revolutionize the bioeconomy market -(www.biolinker.tech) (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The scope of this work is the technical validation of an enzymatic formulation to stabilize LuciStar, an enzyme developed by BIOLINKER in AMBEV Line products. Biolinker's proposal consists in subjecting a luciferase to directed evolution in order to make it functional under the following conditions: pH 2.5-4.5; temperature 3-5 °C; presence of 4-8 % alcohol. These approximate the environme…
In December 2019, the World Health Organization was informed of a number of cases of pneumonia of unknown aetiology in Wuhan, China. Several subsequent investigations identified a new coronavirus, now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in samples of affected patients. The highly sensitive and specific laboratory diagnosis is important for the rapid contro…
In this project, we aim to build a miniaturized, integrated system with parts to be developed in different institutes and to be marketed by the company Biolinker Synthetic Biology. Lab-on-Chip integrated protein synthesis was born as an ambitious project that aims to raise the quality of research, facilitating the work and reducing steps in the production of proteins for research laborato…
| 1 / 1 | Ongoing research grants |
| 2 / 2 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 2 / 2 | Completed scholarships in Brazil |
| 6 / 6 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID